Literature DB >> 21619876

The R(h)oads to Stat3: Stat3 activation by the Rho GTPases.

Leda Raptis1, Rozanne Arulanandam, Mulu Geletu, James Turkson.   

Abstract

The signal transducer and activator of transcription-3 (Stat3) is a member of the STAT family of cytoplasmic transcription factors. Overactivation of Stat3 is detected with high frequency in human cancer and is considered a molecular abnormality that supports the tumor phenotype. Despite concerted investigative efforts, the molecular mechanisms leading to the aberrant Stat3 activation and Stat3-mediated transformation and tumorigenesis are still not clearly defined. Recent evidence reveals a crosstalk close relationship between Stat3 signaling and members of the Rho family of small GTPases, including Rac1, Cdc42 and RhoA. Specifically, Rac1, acting in a complex with the MgcRacGAP (male germ cell RacGAP), promotes tyrosine phosphorylation of Stat3 by the IL6-receptor family/Jak kinase complex, as well as its translocation to the nucleus. Studies have further revealed that the mutational activation of Rac1 and Cdc42 results in Stat3 activation, which occurs in part through the upregulation of IL6 family cytokines that in turn stimulates Stat3 through the Jak kinases. Interestingly, evidence also shows that the engagement of cadherins, cell to cell adhesion molecules, specifically induces a striking increase in Rac1 and Cdc42 protein levels and activity, which in turn results in Stat3 activation. In this review we integrate recent findings clarifying the role of the Rho family GTPases in Stat3 activation in the context of malignant progression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619876      PMCID: PMC3129747          DOI: 10.1016/j.yexcr.2011.05.008

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  71 in total

Review 1.  GDIs: central regulatory molecules in Rho GTPase activation.

Authors:  Céline DerMardirossian; Gary M Bokoch
Journal:  Trends Cell Biol       Date:  2005-07       Impact factor: 20.808

Review 2.  Targeting STAT3 in cancer: how successful are we?

Authors:  Peibin Yue; James Turkson
Journal:  Expert Opin Investig Drugs       Date:  2009-01       Impact factor: 6.206

Review 3.  Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons from toxins.

Authors:  Michel R Popoff; Blandine Geny
Journal:  Biochim Biophys Acta       Date:  2009-04

4.  A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors.

Authors:  Toshiyuki Kawashima; Ying Chun Bao; Yukinori Minoshima; Yasushi Nomura; Tomonori Hatori; Tetsuya Hori; Tatsuo Fukagawa; Toshiyuki Fukada; Noriko Takahashi; Tetsuya Nosaka; Makoto Inoue; Tomohiro Sato; Mutsuko Kukimoto-Niino; Mikako Shirouzu; Shigeyuki Yokoyama; Toshio Kitamura
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

Review 5.  Molecular evolution of the cadherin superfamily.

Authors:  Paco Hulpiau; Frans van Roy
Journal:  Int J Biochem Cell Biol       Date:  2008-10-04       Impact factor: 5.085

Review 6.  Rho GTPase function in tumorigenesis.

Authors:  R Karlsson; E D Pedersen; Z Wang; Cord Brakebusch
Journal:  Biochim Biophys Acta       Date:  2009-03-24

Review 7.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

8.  Cadherin-cadherin engagement promotes cell survival via Rac1/Cdc42 and signal transducer and activator of transcription-3.

Authors:  Rozanne Arulanandam; Adina Vultur; Jun Cao; Esther Carefoot; Bruce E Elliott; Peter F Truesdell; Lionel Larue; Hélène Feracci; Leda Raptis
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

9.  Cell confluency-induced Stat3 activation regulates NHE3 expression by recruiting Sp1 and Sp3 to the proximal NHE3 promoter region during epithelial dome formation.

Authors:  Hsiao-Wen Su; Shainn-Wei Wang; Fayez K Ghishan; Pawel R Kiela; Ming-Jer Tang
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-22       Impact factor: 4.249

10.  Constitutive phosphorylation of a Rac GAP MgcRacGAP is implicated in v-Src-induced transformation of NIH3T3 cells.

Authors:  Noriko Doki; Toshiyuki Kawashima; Yasushi Nomura; Akiho Tsuchiya; Chitose Oneyama; Tsuyoshi Akagi; Yoshihisa Nojima; Toshio Kitamura
Journal:  Cancer Sci       Date:  2009-05-31       Impact factor: 6.716

View more
  41 in total

1.  Toxin-induced RhoA activity mediates CCL1-triggered signal transducers and activators of transcription protein signaling.

Authors:  Simone Reipschläger; Katharina Kubatzky; Sanaz Taromi; Meike Burger; Joachim Orth; Klaus Aktories; Gudula Schmidt
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

2.  PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Authors:  Ester Bonastre; Sara Verdura; Ilse Zondervan; Federica Facchinetti; Sylvie Lantuejoul; Maria Dolores Chiara; Juan Pablo Rodrigo; Julian Carretero; Enric Condom; Agustin Vidal; David Sidransky; Alberto Villanueva; Luca Roz; Elisabeth Brambilla; Suvi Savola; Montse Sanchez-Cespedes
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

Review 3.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

4.  Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.

Authors:  Guan Sun; Ying Cao; Lei Shi; Lihua Sun; Yingyi Wang; Chen Chen; Zhengqiang Wan; Linshan Fu; Yongping You
Journal:  Cancer Biother Radiopharm       Date:  2013-05       Impact factor: 3.099

5.  Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.

Authors:  J E Bohonowych; M W Hance; K D Nolan; M Defee; C H Parsons; J S Isaacs
Journal:  Prostate       Date:  2013-12-16       Impact factor: 4.104

Review 6.  Targeting Cdc42 in cancer.

Authors:  Luis E Arias-Romero; Jonathan Chernoff
Journal:  Expert Opin Ther Targets       Date:  2013-08-19       Impact factor: 6.902

7.  microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.

Authors:  Cheng Zhao; Lin Qi; Minfeng Chen; Longfei Liu; Weiqian Yan; Shiyu Tong; Xiongbing Zu
Journal:  Exp Ther Med       Date:  2015-07-09       Impact factor: 2.447

8.  ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways.

Authors:  Christiane D Fichter; Verena Gudernatsch; Camilla M Przypadlo; Marie Follo; Gudula Schmidt; Martin Werner; Silke Lassmann
Journal:  J Mol Med (Berl)       Date:  2014-08-06       Impact factor: 4.599

Review 9.  Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.

Authors:  Jong Hun Lee; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Ah-Ng Tony Kong
Journal:  Pharmacol Ther       Date:  2012-10-03       Impact factor: 12.310

Review 10.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.